LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Inicio・Lista de Acciones・Bio-Techne Corp

Bio-Techne Corp

Cerrado

Sector Salud

71.52 -0.9

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

71.17

Máximo

71.84

Métricas clave
By Trading Economics
Ingresos	-8.5M 41M
Ventas	-303B 306M
P/B Media del Sector	50.64 103.001
BPA	0.49
Margen de beneficio	13.26
EBITDA	8.2M 92M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 meses	+13.48 upside

Dividendos
By Dow Jones
Próximas Ganancias	29 oct 2024
Fecha Próximo Dividendo	22 nov 2024
Próxima Fecha de Ex Dividendo	7 nov 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-91M 12B
Apertura anterior	72.42
Cierre anterior	71.52

Noticias sobre sentimiento de mercado

By Acuity

50%

114 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bearish Evidence

71.14 / 71.83 Soporte y Resistencia

Bio-Techne Corp Gráfico

Noticias Relacionadas

6 sept 2024, 22:41 UTC

Charlas de Mercado

KinderCare and StandardAero File for IPOs -- Market Talk

6 sept 2024, 21:18 UTC

Principales Noticias

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- Update

6 sept 2024, 21:05 UTC

Principales Noticias

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 4th Update

6 sept 2024, 20:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

6 sept 2024, 20:39 UTC

Ganancias

Update: NIO Stock Caught an Upgrade. Shares Rose. -- Barrons.com

6 sept 2024, 20:35 UTC

Principales Noticias

Stocks Extend Ugly Week of Losses Amid Economic Uncertainty -- WSJ

6 sept 2024, 20:34 UTC

Principales Noticias

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 3rd Update

6 sept 2024, 20:11 UTC

Principales Noticias

Stock Indexes Close Lower After Mixed Jobs Report -- WSJ

6 sept 2024, 19:51 UTC

Principales Noticias

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- WSJ

6 sept 2024, 19:16 UTC

Charlas de Mercado

U.S. Natural Gas Futures Hold Gains -- Market Talk

6 sept 2024, 19:14 UTC

Charlas de Mercado

Oil Futures Extend Losses on Demand Concerns -- Market Talk

6 sept 2024, 19:01 UTC

Charlas de Mercado

Gold Slips on Prevailing Uncertainty -- Market Talk

6 sept 2024, 18:27 UTC

Principales Noticias

JPMorgan Plans to Report Customers Who Exploited TikTok 'Glitch' to Authorities -- WSJ

6 sept 2024, 18:25 UTC

Charlas de Mercado

Broadcom Growth Views Conservative Amid AI Investments -- Market Talk

6 sept 2024, 18:15 UTC

Principales Noticias

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- Update

6 sept 2024, 18:12 UTC

Principales Noticias

Nasdaq Falls 2.5%, Leads Losses After Mixed Jobs Report -- WSJ

6 sept 2024, 17:44 UTC

Charlas de Mercado

Labor Costs Represent Diminishing Risk To Canada CPI, CIBC's Shenfeld Says -- Market Talk

6 sept 2024, 17:30 UTC

Charlas de Mercado

U.S Oil Rig Count Unchanged at 483 -- Market Talk

6 sept 2024, 17:30 UTC

Principales Noticias

Boeing's Starliner Is Returning to Earth Without Its Crew -- WSJ

6 sept 2024, 17:27 UTC

Principales Noticias

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- WSJ

6 sept 2024, 17:00 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

6 sept 2024, 17:00 UTC

Charlas de Mercado

Mexican Inflation Seen Easing in August -- Market Talk

6 sept 2024, 16:36 UTC

Charlas de Mercado

Oil Futures Fall as U.S. Jobs Report Sinks In -- Market Talk

6 sept 2024, 16:35 UTC

Ganancias

Acciones populares

Stocks to Watch Friday: Broadcom, Nvidia, UiPath, Smith & Wesson -- WSJ

6 sept 2024, 16:33 UTC

Adquisiciones, fusiones, absorciones

Salesforce Stock Is on Pace for Longest Losing Streak Since 2008. An Acquisition Isn't Helping. -- Barrons.com

6 sept 2024, 16:20 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

6 sept 2024, 16:20 UTC

Ganancias

Oracle Profit, Revenue Set to Rise in 1Q -- Earnings Preview

6 sept 2024, 16:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

6 sept 2024, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

6 sept 2024, 16:20 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Bio-Techne Corp Esperado

Precio Objetivo

By TipRanks

13.48% repunte

Estimación a 12 meses

Media 81.13 USD 13.48%

Máximo 95 USD

Mínimo 65 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Bio-Techne Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

8 ratings

Comprar

Mantener

Vender

De acuerdo con 8 analistas que ofrecen calificaciones bursátiles a para Bio-Techne Corp Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

71.14 / 71.83Soporte y Resistencia

Recent bearish events outweigh bullish events.

Sentimiento

By Acuity

114 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Bio-Techne Corp

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.